Quidel Corp (QDEL)

188.00 +7.24  +4.01% NASDAQ Nov 27, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/12/2021 Earnings Quidel Corp Fourth Quarter Earnings for 2020 Release
02/12/2021 17:00 EST Misc Quidel Corp Fourth Quarter Earnings Conference Call for 2020
10/29/2020 Earnings Quidel Corp Third Quarter Earnings Result for 2020
10/29/2020 17:00 EDT Misc Quidel Corp Third Quarter Earnings Conference Call for 2020
07/30/2020 17:00 EDT Misc Quidel Corp Second Quarter Earnings Conference Call for 2020
07/30/2020 Earnings Quidel Corp Second Quarter Earnings Result for 2020
05/12/2020 08:30 PDT Misc Quidel Corp Annual General Meeting for 2019
05/06/2020 17:00 EDT Misc Quidel Corp First Quarter Earnings Conference Call for 2020
05/06/2020 Earnings Quidel Corp First Quarter Earnings Result for 2020
02/13/2020 Misc Quidel Corp Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.quidel.com
  • Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=94060&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 12, 2021
  • Last Earnings Release: Oct. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.

Top Fund Holders

Symbol Name Weighting
BCSIX Brown Capital Mgmt Small Co Inv 4.00%
AOFCX Alger Small Cap Focus C 2.63%
XMMO Invesco S&P MidCap Momentum ETF 2.01%
BBH VanEck Vectors Biotech ETF 1.49%
PASSX T. Rowe Price Small-Cap Stock Adv 1.46%
TRSSX T. Rowe Price Instl Small-Cap Stock 1.46%
IVOG Vanguard S&P Mid-Cap 400 Growth ETF 1.08%
PASVX T. Rowe Price Small-Cap Value Adv 1.06%
SMLF iShares MSCI USA Small-Cap Mltfctr ETF 0.92%
MDY SPDR® S&P MIDCAP 400 ETF Trust 0.61%
IVOO Vanguard S&P Mid-Cap 400 ETF 0.61%
DFSTX DFA US Small Cap I 0.49%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.